Uses of Cordyceps sinensis MBF1 in the preparation of anti-radiation damage health products or drugs
TW202629231APending Publication Date: 2026-07-16HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- HANGZHOU ZHONGMEI HUADONG PHARMACEUTICAL CO LTD
- Filing Date
- 2025-11-18
- Publication Date
- 2026-07-16
Smart Images

Figure TWG2TA001069050_001 
Figure TWG2TA001069050_002 
Figure TWG2TA001069050_003
Abstract
This invention discloses the application of Cordyceps sinensis MBF1 in the preparation of health products or drugs for the prevention and / or treatment of radiation damage, particularly its application in the preparation of health products or drugs for the prevention and / or treatment of intestinal radiation damage or hematopoietic system radiation damage caused by ionizing radiation. Cordyceps sinensis MBF1 can significantly improve symptoms caused by intestinal radiation damage, such as shortened colon length, small intestinal tissue damage, and elevated small intestinal inflammation levels, and improve symptoms caused by hematopoietic system radiation damage, such as decreased white blood cell count, decreased spleen index, and / or decreased thymus index. It can serve as a health product or drug for the prevention and treatment of radiation damage, especially intestinal radiation damage or hematopoietic system radiation damage, addressing the current lack of truly effective health products or drugs for the clinical treatment of intestinal radiation damage or hematopoietic system radiation damage. Simultaneously, it provides new ideas and strategies for the development of anti-radiation damage health products or drugs, possessing significant scientific and clinical application value.
Need to check novelty before this filing date? Find Prior Art